Document is current
Any future updates will be listed below
-
Authors
Gerolymos, Cyril https://orcid.org/0009-0008-3082-8104
Garosi, Alexandra
Boyer, Laurent https://orcid.org/0000-0003-1229-6622
Yon, Dong Keon https://orcid.org/0000-0003-1628-9948
Rahmati, Masoud
Gavaudan, Mika https://orcid.org/0009-0005-9401-3586
Fond, Guillaume https://orcid.org/0000-0003-3249-2030
- License Information
-
More Information
Article History
Received: 16 January 2025
Revised: 4 December 2025
Accepted: 25 January 2026
First Online: 10 February 2026
Competing interests
: The authors declare no competing interests.
: Supplementary information is available at MP’s website. The supplementary information contains the study protocol, selection and inclusion criteria, detailed characteristics of the studies, network graphs, forest plots, and league tables for efficacy, discontinuation rates, and tolerability outcomes. It also includes data on consistency, the quality of evidence, the transitivity assumption, and sensitivity analyses. Additional variables can be shared upon request to the corresponding author, with the agreement of Dr. Guillaume Fond and Dr. Cyril Gerolymos.
: All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.
